AstraZeneca’s MedImmune Bid Queried

19:46 PM | May 2, 2007 | Chemical Week Editorial Staff

Shareholders at AstraZeneca’s annual meeting last week raised concerns about the firm’s recent $58/share offer to purchase biotechnology firm MedImmune (Gaithersburg, MD). AstraZeneca’s offer values...